Companies

Drugs Made In America Acquisition Corp. (DMAA) SEC filings

CIK 0002028614 · Blank Checks (SIC 6770) · Nasdaq, Nasdaq, Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025
Net income (USD)5.9 M

Latest filings

FiledFormDescriptionPeriod
2026-10-21425CURRENT REPORT
2026-10-218-KCURRENT REPORT items 1.01,8.01,9.012026-10-13
2026-09-14425CURRENT REPORT
2026-09-148-KCURRENT REPORT items 1.01,9.012026-09-08
2026-08-1410-QQUARTERLY REPORT2026-06-30
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-20425CURRENT REPORT
2026-07-208-KCURRENT REPORT items 1.01,9.012026-07-14
2026-06-26SCHEDULE 13GSCHEDULE 13G
2026-05-1410-QQUARTERLY REPORT2026-03-31
2026-05-14SCHEDULE 13GSCHEDULE 13G
2026-05-05425CURRENT REPORT
2026-05-058-KCURRENT REPORT items 1.01,9.012026-04-29
2026-05-018-KCURRENT REPORT items 5.03,5.07,8.01,9.012026-04-27
2026-04-288-KCURRENT REPORT items 1.01,9.012026-04-22
2026-04-16DEFR14AREVISED DEFINITIVE PROXY STATEMENT
2026-04-1510-KANNUAL REPORT2025-12-31
2026-04-14DEF 14APROXY STATEMENT2026-04-27
2026-04-088-KCURRENT REPORT items 8.01,9.012026-04-07
2026-04-01NT 10-KNOTIFICATION OF LATE FILING2025-12-31
2026-03-27PRE 14APROXY STATEMENT2026-03-27
2026-03-278-KCURRENT REPORT items 1.01,2.03,8.01,9.012026-03-23

Forms on file (last 1,000): 8-K 15, 4 8, SCHEDULE 13G 7, 3 6, SCHEDULE 13G/A 6, S-1/A 6, 10-Q 5, CORRESP 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=DMAA (0.002 USD), /gw/filings/filings?ticker=DMAA&form=8-K, /gw/filings/facts?ticker=DMAA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange